C[lustering]{.smallcaps} of voltage-gated sodium channels at the axon proximal segments and nodes of Ranvier is believed to be essential for production and propagation of action potentials in myelinated axons. The mechanisms responsible for concentrating sodium channels in these specialized membrane domains in axons are not established, but are likely to involve specialized members of the ankyrin family of spectrin-binding proteins. Ankyrins are membrane-associated proteins that bind to certain ion channels, including the voltage-sensitive sodium channel, and have the potential to couple these channels to the spectrin--actin network ([@B33]; [@B4]; [@B5]). Ankyrins also bind through their conserved membrane-binding domains to cell adhesion molecules of the L1 cell adhesion molecule (CAM) family ([@B11], 1996; [@B12]; [@B17]), and have been proposed to form lateral complexes involving L1 CAMs and ion channels ([@B29],*b*; [@B28]). Ankyrins are concentrated at physiological sites with a high density of voltage-sensitive sodium channels including nodes of Ranvier, axon proximal segments, and postsynaptic folds of the neuromuscular junction ([@B16]; [@B25]). The isoforms of ankyrin colocalized with voltage-sensitive sodium channels at nodes of Ranvier and axon proximal segments have been identified as 480/270-kD alternatively spliced variants of ankyrin~G~ ([@B26]). An ankyrin~G~ polypeptide also has been identified at the neuromuscular junction ([@B37]). In addition to ankyrin~G~, isoforms of neurofascin and NrCAM, which are members of the L1 CAM family, have been identified at nodes of Ranvier and axon proximal segments ([@B13]).

480/270-kD ankyrin~G~ colocalizes with sodium channel clusters in amyelinated regions of peripheral nerves of the dystrophic mouse ([@B14]), and in axons of cultured retinal ganglion neurons in the absence of direct contact with glial cells ([@B23]). These results imply targeting of channels and ankyrin to sites defined by intrinsic polarity to the axon, independent of cell--cell contact, although soluble factors released by glial cells may play a role ([@B23]). 480/270-kD ankyrin~G~ also colocalized in the developing sciatic nerve in clusters containing sodium channels, neurofascin, and NrCAM ([@B28]). The earliest event observed in myelinating nerve, preceding expression of myelin-associated glycoprotein (MAG) by Schwann cells, was clustering of neurofascin and NrCAM, which were followed by ankyrin and sodium channels. These observations led to the proposal that extracellular signals, perhaps related to the soluble factor described by [@B23], induce clustering of neurofascin and NrCAM, which in turn recruit ankyrin~G~ and sodium channels ([@B28]).

Mice deficient in cerebellar ankyrin~G~ polypeptides have recently been developed by targeted gene disruption (Zhou, D., S. Lambert, P. Melen, S. Carpenter, L. Boland, and V. Bennett, manuscript submitted for publication). Cerebellar neurons of these ankyrin~G~ (−/−) mice fail to concentrate sodium channels as well as neurofascin at axon proximal segments. These findings demonstrate that 480/270-kD ankyrin~G~ is required for clustering of both sodium channels and neurofascin at axon proximal segments. Neurofascin and L1 CAMs therefore are not sufficient to provide the initial targeting signal for ankyrin~G~ at axon proximal segments, in contrast to expectations from observations of development of the node of Ranvier ([@B28]).

This paper addresses the mechanism for restriction of 270-kD ankyrin~G~ to axon proximal segments of cultured dorsal root ganglion (DRG)^1^ neurons. A conclusion is that multiple ankyrin~G~-specific domains, in addition to the conserved membrane-binding domain, cooperate in targeting and restriction of ankyrin~G~ to axon proximal segments. Moreover, measurements of fluorescence recovery after photobleaching (FRAP) of green fluorescent protein (GFP)- tagged ankyrin constructs cotransfected with neurofascin in a nonneuronal cell line demonstrate that the membrane-binding, spectrin-binding, tail and serine-rich domains each contribute to immobilization of 270-kD ankyrin~G~--neurofascin complexes in the plasma membrane. These results provide strong evidence that association between the ankyrin~G~ membrane-binding domain and neurofascin is not sufficient to restrict ankyrin~G~ to axon proximal segments, and that other ankyrin~G~ domains and yet to be defined protein interactions are also involved.

Materials and Methods {#MaterialsMethods}
=====================

DRG Culture
-----------

The culture of embryonic DRG was modified from methods previously described ([@B24]). In brief, DRGs were obtained from E15 rat embryos and plated on laminin-coated dishes after dissociation with 0.02% collagenase and 0.25% trypsin-EDTA. The medium was changed from normal medium (10% FBS in DME, 100 ng/ml NGF) to the defined medium (1× N1 additive \[Sigma Chemical Co., St. Louis, MO\], 100 ng/ml NGF, 10 μM FdU and 10 μM uridine in DME) 24 h after plating. The culture was kept in the defined medium for 2 d before changing back to normal medium for an additional 2 d. The antimitotic cycle was repeated once to kill most of dividing nonneuronal cells. After 8 d in culture, DRG neurons are ready for immunofluorescence and gene gun transfection.

Preparation of cDNA Constructs
------------------------------

Assembly of the full-length cDNA for 270-kD ankyrin~G~ (Ank270) was achieved by ligating the first half of membrane-binding domain, which was isolated from adult rat brain 5′-stretch plus cDNA library (Clontech Laboratories Inc., Palo Alto, CA) and confirmed by DNA sequencing, with construct M-Sb-Sr-T-C ([@B39]) through the EcoRI-NsiI sites. The COOH-terminal domain of 270-kD ankyrin~G~ was PCR amplified and introduced into the SalI site of pEGFP-N1 vector (Clontech Laboratories Inc.), while keeping in-frame with the downstream EGFP protein (Ank-Ct). The full-length 270-kD ankyrin~G~ with GFP tagged at its COOH terminus (see Fig. [2](#F2){ref-type="fig"}, *Ank270--GFP*) was prepared by ligating the EcoRI-EcoRV fragment of construct Ank270 into the EcoRI-EcoRV sites of construct Ank-Ct. The cDNA construct for 190-kD ankyrin~G~ (see Fig. [2](#F2){ref-type="fig"}, *Ank270\[ΔSR,T\]--GFP*) was prepared similarly except using construct M-Sb-C ([@B39]) instead of M-Sb-Sr-T-C. The cDNA construct lacking the first half of the membrane-binding domain (corresponding to the amino acids 0--393 of human ankyrin~G~ \[[@B26]\]) was prepared by putting the EcoRV fragment of M-Sb-Sr-T-C ([@B39]) into the corresponding site of the construct Ank-Ct (see Fig. [2](#F2){ref-type="fig"}, *Ank270\[ΔM1,2\]--GFP*). The construct containing only the membrane-binding and the spectrin binding domain (see Fig. [2](#F2){ref-type="fig"}, *Ank270\[ΔSR,T,Ct\]--GFP*) was obtained by replacing the EcoRV-NotI fragment of construct Ank270\[ΔSR,T\]--GFP with a PCR-amplified EGFP sequence. The construct expressing the membrane-binding domain was made by introducing a PCR-amplified sequence into the EcoRI-SalI sites of pEGFP-N1 vector while keeping in-frame translation of the downstream EGFP (M--GFP). Constructs expressing the serine-rich (SR-GFP), spectrin-binding (SB-GFP), tail (T-GFP), and COOH-terminal (Ct-GFP) domains were prepared similarly. To make a construct with deletion of the serine-rich domain (see Fig. [2](#F2){ref-type="fig"}, *Ank270\[ΔSR\]--GFP*), a PCR-amplified fragment of the tail domain of the 270-kD ankyrin~G~ was introduced into the EcoRV site of construct Ank270(ΔSR,T)--GFP.

The full-length rat neurofascin cDNA with a hemagglutinin (HA) epitope at the NH~2~ terminus ([@B17]) was cut out by HindIII-NotI from PBluescript KS vector (Stratagene, La Jolla, CA), and subcloned into the corresponding sites of pEGFP-N1 vector (Clontech Laboratories Inc.). The resultant construct (see HA--NF in Fig. [2](#F2){ref-type="fig"}) does not contain the EGFP sequence. The cytoplasmic domain-deleted neurofascin (see HA--NF\[ΔCD\] in Fig. [2](#F2){ref-type="fig"}) was made by replacing the ScaI-NotI fragment of construct HA--NF with a PCR-amplified fragment containing the sequence of the ScaI-ApaI fragment with a stop codon right after the ApaI site. The extracellular domain-truncated neurofascin (see Fig. [2](#F2){ref-type="fig"}, *HA--NF\[ΔEC\]*) was prepared through two steps. First, the 5′-untranslated region of neurofascin with the start codon, the signal peptide, and the HA tag was PCR amplified and subcloned into the BglII-HindIII sites of pEGFP-N1 vector. Then the transmembrane and cytoplasmic domains were introduced into the HindIII-NotI sites of the first-step construct. Construct with the full-length neurofascin tagged with EGFP at its COOH terminus was obtained also by two steps (see HA--NF--GFP in Fig. [2](#F2){ref-type="fig"}). The HindIII-ApaI fragment of neurofascin in pBluescript KS vector was transferred into the corresponding sites of pEGFP-N3 vector (Clontech Laboratories Inc.) so as to keep in-frame reading of EGFP with the introduced neurofascin fragment. Then a PCR-amplified cytoplasmic domain of neurofascin was introduced into the ApaI site of the above construct.

cDNA Transfection and Immunofluorescence
----------------------------------------

DRG cultures were transfected using Helios™ Gene Gun system following the manufacturer\'s instructions. 150--180 psi pressure was used to deliver cDNA-coated microcarriers into DRG cultures. 24 h after transfection, DRG cultures were fixed in 2% paraformaldehyde and then subjected to 0.5% Triton X-100 permeabilization before being stained with a polyclonal antibody specific for GFP (Clontech Laboratories Inc.). Immunofluorescence for endogenous proteins was performed similarly.

Human kidney 293 cells were cultured in 10% FBS and DME (GIBCO BRL, Gaithersburg, MD) and transfected by Lipofectamine according to the manufacturer\'s protocol (GIBCO BRL). 24 h after transfection, cultures were either subject to photobleaching (see below) or fixed in 2% paraformaldehyde and then stained with a monoclonal antibody specific for the HA epitope of neurofascin (Berkeley Antibody Co., Richmond, CA).

Chicken polyclonal antibody against 270/480-kD ankyrin~G~ ([@B39]) and rabbit polyclonal antibodies against ankyrin~B~ ([@B6]), brain spectrin ([@B7]), and neurofascin ([@B13]) were described previously. TRITC-conjugated goat anti--mouse and goat anti--rabbit, and FITC-conjugated goat anti--rabbit antibodies were purchased from Rockland (Gilbertsville, PA). FITC-conjugated donkey anti--chicken was obtained from Jackson ImmunoResearch Laboratories (West Grove, PA).

Fluorescence Recovery Measurement after Photobleaching
------------------------------------------------------

Photobleaching of the cytoplasm-localized Ank270--GFP was performed essentially as described, using an Odyssey confocal imaging system ([@B17]). Photobleaching of the plasma membrane-localized transfected proteins was performed in a Zeiss LSM 410 laser confocal system coupled with an UV laser (Carl Zeiss Inc., Thornwood, NY). A selected region enclosing the plasma membrane to be studied was photobleached using the UV laser beam for 60 ms. The radii of photobleached regions range from 1 to 3 μm. The fluorescence recovery inside the photobleached area was immediately recorded by a home-designed program containing several 'Time Series\' with different time intervals. The recorded data was analyzed using NIH Image software (Bethesda, MD). The recovered fraction was calculated as (I~e~−I~i~)/(I~o~−I~i~). I~o~, the average intensity of the selected region before photobleaching; I~i~, the average intensity of the selected region immediately after photobleaching; and I~e~, the average intensity of the selected region after 50 s of recovery. The recovery rate was calculated as *w* ^2^/*t*, where *w* is the radius of the photobleached region, and *t* is the time in seconds required for the average intensity of the selected region to recover to the value of (I~e~+ I~i~)/2.

Results {#Results}
=======

Native Ankyrin~G~ and Neurofascin but Not Ankyrin~B~and Spectrin Are Restricted to Axon Proximal Segments of DRG Neurons
------------------------------------------------------------------------------------------------------------------------

480/270-kD ankyrin~G~ (Fig. [1](#F1){ref-type="fig"}, *A*, *D*, and *G*) and neurofascin (Fig. [1](#F1){ref-type="fig"} *H*) are concentrated at the axolemma of axon proximal segments of cultured embryonic DRG neurons. Ankyrin~G~ also is associated with the plasma membrane in cell bodies of neurons, although at a lower level than in the axon proximal segment (Fig. [1](#F1){ref-type="fig"}, *A*, *D*, and *G*). Ankyrin~B~, in contrast, is distributed along the length of axons and is present in only low levels in axon proximal segments (Fig. [1](#F1){ref-type="fig"} *B*). Ankyrin~B~ also exhibits only minimal staining in the cell body (Fig. [1](#F1){ref-type="fig"} *B*). Spectrin is distributed along axons in a pattern resembling ankyrin~B~ (Fig. [1](#F1){ref-type="fig"} *E*). These results demonstrate that cultured DRG neurons have a polarized distribution of native ankyrin~G~ and neurofascin in axon proximal segments similar to localization of these proteins in sections of intact brain tissue ([@B26]; [@B13]).

Ankyrin~G~ and ankyrin~B~ both bind to neurofascin with high affinity through their membrane-binding domains, which share 74% amino acid identity ([@B11]; [@B12]; [@B26]; [@B41]). Thus, enrichment of neurofascin and ankyrin~G~, but not ankyrin~B~, at axon proximal segments of DRG neurons (Fig. [1](#F1){ref-type="fig"}, *C* and *I* ) suggests a mechanism independent of neurofascin for targeting ankyrin~G~ specifically to the axolemma of axon proximal segments. The targeting protein(s) are not currently known spectrin polypeptides, based on lack of concentration of spectrin at axon proximal segments (Fig. [1](#F1){ref-type="fig"} *F*).

Unique Serine-rich and Tail Domains of 270-kD Ankyrin~G~ Contribute to Restriction of Ankyrin~G~at Axon Proximal Segments
-------------------------------------------------------------------------------------------------------------------------

Ankyrin~G~ is distinguished from ankyrin~B~ by a unique O-GlcNAc--glycosylated serine-rich domain and a highly divergent tail domain ([@B26]; [@B39]). In addition, ankyrin~G~ and ankyrin~B~ differ in sequence in portions of the spectrin-binding domain and in the COOH-terminal domain. To identify the roles of the serine-rich and tail domains in targeting 480/270-kD ankyrin~G~ to axon proximal segments, we transfected DRG neurons with cDNAs, each with a COOH-terminal GFP tag, encoding 270-kD ankyrin~G~ and its variants lacking the serine-rich and/or tail domains (Fig. [2](#F2){ref-type="fig"}). The distribution of transfected 270-kD ankyrin~G~ (Fig. [2](#F2){ref-type="fig"}, *Ank270--GFP*) is visualized by immunostaining of the COOH-terminal GFP tag, and is highly restricted to the axolemma of the proximal segment in a pattern similar to native 480/270-kD ankyrin~G~ (Fig. [3](#F3){ref-type="fig"}, *A* and *B*). The intensity of immunofluorescence attenuates abruptly beyond the proximal segment (Fig. [3](#F3){ref-type="fig"} *A* and Fig. [4](#F4){ref-type="fig"}, *A* and *B*), which is usually tens of micrometers in length in DRG neurons ([@B19]). Double labeling of cultures cotransfected with GFP-tagged 270-kD ankyrin~G~ (Fig. [3](#F3){ref-type="fig"} *D*) and HA-tagged cytoplasmic domain-truncated neurofascin, HA--NF(ΔCD) (Fig. [2](#F2){ref-type="fig"} and Fig. [3](#F3){ref-type="fig"} *E*), indicates the polarized distribution of the transfected ankyrin~G~ is not due to incomplete extension or partial optical sectioning of axons since the full length of the axon is well displayed by mutant neurofascin (Fig. [3](#F3){ref-type="fig"} *E*). The relatively even distribution of cytoplasmic domain-truncated neurofascin along the length of the axon also suggests that the extracellular and transmembrane domains of neurofascin are not sufficient to achieve polarized localization at the proximal segment. Some GFP-tagged ankyrin~G~ is also targeted to areas of the plasma membrane of the cell body, at levels approximating those in the proximal segments (Fig. [3](#F3){ref-type="fig"} *C*). This behavior is in contrast to the distribution of native ankyrin~G~ and could represent a consequence of high levels of expression of the transfected ankyrin~G~.

Transfected 190-kD ankyrin~G~ (refer to Fig. [2](#F2){ref-type="fig"}, *Ank270 \[ΔSR,T\]--GFP*), which lacks the unique serine-rich and tail domains of 270-kD ankyrin~G~ ([@B26]), is also located at the axolemma of the proximal segment (Fig. [3](#F3){ref-type="fig"}, *F* and *G*). However, 190-kD ankyrin~G~ is much less restricted, and distributes well beyond the proximal segment into the axon (Fig. [3](#F3){ref-type="fig"} *F* and Fig. [4](#F4){ref-type="fig"}, *A* and *B*). The distance required for the intensity of immunofluorescence to drop to one-third of the intensity at the proximal segment is more than twice as long for 190-kD ankyrin~G~ than for 270-kD ankyrin~G~ (Fig. [4](#F4){ref-type="fig"} *B*). Insertion of the tail domain into 190-kD ankyrin~G~ (refer to Fig. [2](#F2){ref-type="fig"}, *Ank270\[ΔSR--GFP\]*) improves, but does not completely restore, the restriction of the transfected ankyrin~G~ to the proximal area of the axon (Fig. [3](#F3){ref-type="fig"} *I* and Fig. [4](#F4){ref-type="fig"}, *A* and *B*). Ank270(ΔSR)--GFP distributes in a punctate pattern different from that of 270-kD ankyrin~G~ and 190-kD ankyrin~G~ (Fig. [3](#F3){ref-type="fig"}, *J* and *K*). These data suggest that the unique serine-rich domain and tail domain of 270/480-kD ankyrin~G~contribute to restriction of ankyrin~G~ at axon proximal segments.

Spectrin-binding and Tail Domains of Ankyrin~G~ Contain Specific Plasma Membrane-binding Sites
----------------------------------------------------------------------------------------------

To examine which domain(s) are sufficient for restriction of ankyrin~G~ at the axolemma of axon proximal segments, different domains of 270-kD ankyrin~G~ were individually introduced into DRG neurons. The membrane-binding domain (Fig. [5](#F5){ref-type="fig"}, *E* and *F*), the serine-rich domain (Fig. [5](#F5){ref-type="fig"}, *G* and *H*) and the COOH-terminal domain (Fig. [5](#F5){ref-type="fig"}, *I* and *J*) are predominantly distributed throughout the cytoplasm of the cell body and the axon, but are not concentrated at the axolemma. The failure in recruiting the membrane-binding domain to the plasma membrane might be a consequence of over-expression and does not exclude the possibility of a limited number of binding sites. The spectrin-binding domain (Fig. [5](#F5){ref-type="fig"}, *A* and *B*) and the tail domain (Fig. [5](#F5){ref-type="fig"}, *K* and *L*), on the other hand, were targeted to the axolemma of the proximal segment as well as the plasma membrane of the cell body. The spectrin-binding domain also distributes in a punctate pattern similar to that of Ank270(ΔSR)--GFP (Fig. [5](#F5){ref-type="fig"}, *A* and *B*). However, neither the spectrin-binding nor tail domains are restricted to the proximal segment as the case with transfected 270-kD ankyrin~G~, and their intensity-drop profiles along axons are similar to that of 190-kD ankyrin~G~ (Fig. [6](#F6){ref-type="fig"}, *A* and *B*). These data suggest an important role for plasma membrane-binding sites in the spectrin-binding and the tail domain for restriction of ankyrin~G~ at axon proximal segments. The restrictive effect of the serine-rich domain (refer to Fig. [3](#F3){ref-type="fig"} *I* and see Fig. [5](#F5){ref-type="fig"}, *G* and *H*) seems unrelated to targeting to the plasma membrane, at least as resolved by these techniques.

The transfected spectrin-binding domain of ankyrin~B~ is not targeted to the axolemma and is distributed in the axoplasm and the cytoplasm of the cell body (Fig. [5](#F5){ref-type="fig"}, *C* and *D*). The spectrin-binding domain of ankyrin~G~ thus contains targeting information lacking in the spectrin-binding domain of ankyrin~B~, and could contribute to specific restriction of ankyrin~G~ to axon proximal segments.

Ankyrin~G~ Domains Cooperate in Restricting the Lateral Mobility of Ankyrin~G ~--Neurofascin Complexes
------------------------------------------------------------------------------------------------------

The serine-rich domain and possibly other domains of 270-kD ankyrin~G~ could contribute to restriction of ankyrin~G~ to axon proximal segments through interactions limiting lateral mobility in addition to binding to membrane-targeting sites. Activity of ankyrin~G~ domains in immobilizing ankyrin~G~--neurofascin complexes was evaluated in a nonneuronal cell line (293 cells from human embryonic kidney) cotransfected with GFP-tagged ankyrin~G~ and HA-tagged neurofascin (Fig. [7](#F7){ref-type="fig"}). 270-kD ankyrin~G~ transfected alone is located throughout the cytoplasm of 293 cells (Fig. [7](#F7){ref-type="fig"} *A*). However, 270-kD ankyrin cotransfected with neurofascin is recruited to the plasma membrane (Fig. [7](#F7){ref-type="fig"}, *B* and *C*). Targeting of transfected ankyrin~G~ in 293 cells to the plasma membrane is solely governed by interactions between the membrane-binding domain and cotransfected neurofascin, since the membrane-binding domain of ankyrin~G~ alone is sufficient for membrane recruitment by co transfected neurofascin (Fig. [7](#F7){ref-type="fig"}, *D* and *E*). Moreover, deletion of the first half of the membrane-binding domain abolishes recruitment of ankyrin~G~ to the plasma membrane even though the COOH-terminal, tail, serine-rich, and spectrin-binding domains are still present (Fig. [7](#F7){ref-type="fig"}, *F* and *G*). The structural requirements for activity of neurofascin in recruiting ankyrin~G~ are explored in a separate study ([@B41]).

Dynamic behavior of GFP-tagged ankyrin~G~--neurofascin complexes were examined by measurements of FRAP of the GFP signal (Fig. [8](#F8){ref-type="fig"}). Dynamic parameters were first determined for GFP-tagged 270-kD ankyrin~G~ (Ank270-- GFP) alone, which was localized in the cytoplasm, and for GFP-tagged neurofascin (HA--NF--GFP) alone. Cytoplasmic 270-kD ankyrin~G~ exhibits rapid and nearly complete recovery after photobleaching (91% recovery at a rate of 1.1 × 10^−7^ cm^2^/s), consistent with the diffusion rate of a protein in solution (Fig. [8](#F8){ref-type="fig"}, *A* and *B*). GFP-tagged neurofascin (HA--NF--GFP) transfected in the absence of cotransfected ankyrin~G~ exhibited a 72% recovery at a rate of 5.6 × 10 cm^2^/s (Fig. [8](#F8){ref-type="fig"}, *A* and *C*). This rate is comparable to other membrane proteins that are freely diffusing in plasma membranes ([@B21]; [@B38]). In contrast, plasma membrane-associated 270-kD ankyrin~G~ (Ank270--GFP cotransfected with HA--NF) displays a greatly reduced rate (4 × 10^−10^ cm^2^/s) as well as extent (10%) of FRAP (Fig. [8](#F8){ref-type="fig"}, *A*, *B,* and *C*). This dramatic decrease of membrane lateral mobility is not due to lateral association of the extracellular domain of neurofascin with itself or with other membrane-spanning proteins, since deletion of the extracellular domain of neurofascin has little effect on membrane dynamic behavior of cotransfected 270-kD ankyrin~G~ (Ank270--GFP with HA--NF\[ΔEC\] in Fig. [8](#F8){ref-type="fig"}, *A* and *B*). Thus, 270-kD ankyrin~G~ provides the major contribution to immobilization of ankyrin-neurofascin complexes in the plane of the plasma membrane.

The role of ankyrin~G~ domains in immobilizing neurofascin were evaluated using a range of ankyrin~G~ constructs (refer to Fig. [2](#F2){ref-type="fig"}, and see Fig. [8](#F8){ref-type="fig"}, *A* and *C*). The lateral mobility of the membrane-localized complexes formed by cotransfected neurofascin (HA--NF) and the membrane-binding domain of ankyrin~G~ (M-GFP) exhibits more than a 50% reduction of rate of recovery (2.6 × 10^−9^ cm^2^/s) and a 30% decrease of extent of recovery (51%) compared with behavior of GFP neurofascin (HA--NF--GFP) alone. Addition of the spectrin-binding domain to the membrane-binding domain (Ank270\[ΔSR,T,Ct\]--GFP) results in another 50% reduction in the rate of recovery (1.4 × 10^−9^ cm^2^/s) and a decrease in extent of recovery to ∼25% (refer to Fig. [4](#F4){ref-type="fig"}). Subsequent addition of the COOH-terminal domain (Ank270\[ΔSR,T\]--GFP), however, had no apparent effect. Addition of the tail domain (Ank270\[ΔSR\]-- GFP) further decreased the rate (7 × 10^−10^ cm^2^/s) and the extent (16%) of recovery. Finally, addition of the serine-rich domain (Ank270--GFP) had another reduction in rate to 4 × 10 cm^2^/s and extent of recovery to 10 percent.

Discussion {#Discussion}
==========

The current paradigm for organization of ankyrin--membrane protein complexes derives from the erythrocyte membrane, and envisions monomeric ankyrin forming lateral complexes between integral proteins via the multivalent membrane-binding domain and spectrin via the spectrin-binding domain ([@B2]; [@B29],*b*). This study provides evidence that a simple erythrocyte-based model is not adequate to explain ankyrin~G~ organization at axon proximal segments. The spectrin-binding, serine-rich, and tail domains all contribute to restriction of ankyrin~G~ to the axonal plasma membrane in DRG neurons. Multiple ankyrin~G~ domains also contribute to limiting the lateral mobility of ankyrin--neurofascin complexes in a nonneuronal cell. The ankyrin~G~-specific spectrin-binding and tail domains are capable of binding directly to sites on the plasma membrane of axon proximal segments and neuronal cell bodies, and presumably have yet to be identified docking sites. The serine-rich domain, which is present only in 480- and 270-kD ankyrin~G~ polypeptides, contributes to restriction of ankyrin~G~ to axon proximal segments as well as limiting lateral diffusion of ankyrin~G~--neurofascin complexes. Ankyrin~G~ thus functions as an integrated mechanism involving cooperation among multiple domains heretofore regarded as modular units. This complex behavior explains the ability of ankyrin~B~ and ankyrin~G~ to sort to distinct sites in neurons and the fact that these ankyrins do not compensate for each other in ankyrin gene knockouts in mice (Zhou, D., S. Lambert, P. Malen, S. Carpenter, L. Boland, and V. Bennett, manuscript submitted for publication) (Scotland, P., D. Zhou, H. Benveniste, and V. Bennett, manuscript submitted for publication).

The mechanism for restriction of dynamic behavior of neurofascin by ankyrin~G~ could result from self-association of ankyrin~G~ domains and/or low affinity interaction with membrane or cytoskeletal proteins. For example, ankyrin associates with micromolar affinity with microtubules ([@B3]). Association of transfected ankyrin~G~ with endogenous spectrin does not seem likely, since ankyrin~G~ remained in the cytoplasm in the absence of cotransfected neurofascin, whereas spectrin in these cells is primarily localized at the plasma membrane ([@B41]). As an alternative to specific protein interactions, ankyrin~G~ could be nonspecifically trapped in the membrane-apposed cytoskeletal meshwork, according to the membrane-skeleton fence model ([@B27]; [@B22]). Further analysis will be required to differentiate these possibilities.

Functions attributed so far to the spectrin-binding domain of ankyrin have been association with spectrin ([@B1]; [@B8],*b*), and contact with the Na^+^/K^+^ ATPase ([@B10]). Disruption of the spectrin network abolishes the polarized distribution of ankyrin as well as Na^+^/K^+^-ATPase at cell--cell contact sites in cultured cells ([@B20]). However, antibody against total brain spectrin revealed no enrichment of spectrin at axon proximal segments of DRG neurons and thus, known spectrins are unlikely to provide a sufficient mechanism to specifically enrich ankyrin~G~ at the sites. A similar lack of correlation between spectrin and ankyrin~G~ has been reported at nodes of Ranvier in sciatic nerves, where spectrin is continuously distributed along plasma membranes of axons and the myelinating Schwann cell ([@B28]). Since different spectrin isoforms have different affinities for ankyrins ([@B18]; [@B8]), one explanation of these results is the existence of a novel isoform of spectrin which is targeted to axon proximal segments and nodes of Ranvier, but is not identified by our current antibody. Alternatively, a novel ankyrin~G~-binding protein unrelated to spectrin could be targeted to axon proximal segments. In addition, a yet to be identified protein at the axolemma of axon proximal segments provides a binding site for the tail domain of 270-kD ankyrin~G~.

The traditional interactions between membrane proteins and ankyrin mediated by the membrane-binding domain of ankyrin may not provide the initial step in restriction of ankyrin at the axolemma of axon proximal segments. Instead, enrichment of ankyrin, which could be achieved through combined influences of the spectrin-binding, tail, and serine-rich domains, may precede and direct assembly of membrane proteins at the sites. Failure of transfected mutant neurofascin with a deleted cytoplasmic domain to be concentrated at axon proximal segments (Fig. [3](#F3){ref-type="fig"} *E*) favors the possibility that the ankyrin-binding activity, which is located in the cytoplasmic domain of neurofascin ([@B12]) (Zhang, X., J.D. Davis, S. Carpenter, and V. Bennett, manuscript in preparation), is required for restriction of neurofascin at these sites. Moreover, the disrupted assembly of neurofascin as well as sodium channels at axon proximal segments in ankyrin~G~ (−/−) mice further supports the role of ankyrin in directing membrane proteins to axon proximal segments (Zhou, D., S. Lambert, P. Malen, S. Carpenter, L. Boland, and V. Bennett, manuscript submitted for publication).

The potential defining role of ankyrin in clustering of membrane proteins at axon proximal segments is inconsistent with conclusions from analysis of morphogenesis of nodes of Ranvier, suggesting that clusters of neurofascin/ NrCAM provide sites for subsequent assembly of ankyrin and sodium channels ([@B28]). The disparity could be attributed to the potentially different mechanisms used in establishment of axon proximal segments and nodes of Ranvier, despite similarities in their molecular organization ([@B26]; [@B13]; [@B5]) and ultrastructure ([@B36]). Clustering of ankyrin or sodium channels at axon proximal segments does not require the presence of glial cells and thus is most likely determined by an intrinsic polarity of neurons (Fig. [3](#F3){ref-type="fig"}, *A*, *D,* and *G*) ([@B23]). In contrast, clustering of ankyrin and sodium channels in the axonal region beyond the proximal segment, which is regarded as an early event for assembly of nodes of Ranvier, requires signals from glial cells, although whether these signals are diffusable or require direct glia--axon contact has been debated ([@B32]; [@B15]; [@B34], [@B35]; [@B14]; [@B23]). Clustering of neurofascin/NrCAM at the initial sites of nodes of Ranvier provides a potential mechanism to bridge glial cell signals to intracellular determinants, such as clustering of ankyrin, during the early development of nodes of Ranvier. On the other hand, the unique position of axon proximal segments might be sufficient to provide a cue to polarize the molecular composition at this region characterized by concentration of ankyrin and subsequent recruitment of ankyrin-binding membrane proteins.

In carefully timed neuronal Schwann cell cocultures, we have observed that clustering of ankyrin precedes clustering of sodium channels. In addition, each MAG-positive myelinating Schwann cell has two ankyrin clusters at each end of this Schwann cell. These ankyrin clusters are covered by processes of the myelinating Schwann cell, suggesting axon-Schwann cell contact defines clustering as well as the clustering sites of ankyrin ([@B40]). These results indicate that ankyrin, as at axon proximal segments, is a candidate to direct assembly of sodium channels at the precursor sites of nodes of Ranvier, although the role of glial cells may differ between nodes and proximal segments.

This paper suggests a complicated and cooperative scenario for establishment of the specialized membrane domain of axonal proximal segments, which may involve not only interactions between membrane proteins and ankyrin but also ankyrin and other yet to be identified proteins which precede ankyrin at these sites. Isoforms of ankyrin~G~ also are targeted to sites of cell--cell contact in epithelial tissues ([@B31]), and proteins similar to those of axon proximal segments could also be required for epithelial polarity. A challenge for future work will be to fully elucidate the structural pathway leading to assembly of ankyrin-based membrane domains.
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CAM

:   cell adhesion molecule

DRG

:   dorsal root ganglion

FRAP

:   fluorescence recovery after photobleaching

GFP

:   green fluorescent protein

HA

:   hemagglutinin

![Schematic diagram of cDNA constructs used in transfection experiments. Preparation of cDNA constructs of ankyrin and neurofascin is described in Materials and Methods. Ank270--GFP represents the full-length 270-kD ankyrin~G~ with GFP tag at its COOH terminus. Construct Ank270(ΔSR)--GFP has a deleted serine-rich domain and Ank270(ΔM1,2)--GFP lacks the first half of the membrane-binding domain. Construct Ank270(ΔSR,T)-- GFP is a 190-kD natural isoform of ankyrin~G~ without the serine-rich and tail domains. Deletion of the COOH-terminal domain from construct Ank270(ΔSR,T)--GFP results in construct Ank270(ΔSR,T,Ct)--GFP. M-GFP, SB-GFP, SR-GFP, T-GFP, and Ct-GFP represent the membrane-binding domain, the spectrin-binding domain, the serine-rich domain, the tail domain, and the COOH-terminal domain, respectively. In the neurofascin construct family, construct HA--NF contains the full-length of neurofascin with HA-epitope at the NH~2~ terminus. Constructs HA-- NF(ΔEC) and HA--NF(ΔCD) have the deletion of the extracellular domain and the cytoplasmic domain respectively. HA--NF--GFP contains a GFP tag at the COOH terminus of the full-length neurofascin.](JCB9806060.f2){#F2}

![Distribution of 270/ 480-kD native ankyrin~G~, ankyrin~B~, spectrin, and neurofascin in cultured DRG neurons. 270/480-kD ankyrin~G~ (*A*) and ankyrin~B~ (*B*) are double labeled in 9-d-old embryonic DRG culture. (*C*) Composite image of *A* and *B*. Ankyrin~G~ is concentrated at the proximal segment (*A*, *arrows*), whereas ankyrin~B~ is more evenly distributed in axons (*B*). Spectrin (*E*), compared with double-labeled ankyrin~G~ (*D*, *arrow*, proximal segment), also lacks polarized distribution at the proximal segment. (*F*) Composite image of *D* and *E*. Neurofascin (*H*), a member of L1 CAM family of cell adhesion molecules, is concentrated and colocalized with ankyrin~G~ at the proximal segment (*G*, *arrow*). (*I*) Composite image of *G* and *H*. The *green channel* (FITC) corresponds to ankyrin~G~ stain whereas the *red channel* (TRITC) represents other proteins. Bar, 25 μm.](JCB9806060.f1){#F1}

![The unique serine-rich and tail domain of ankyrin~G~ contribute to restriction of 270-kD ankyrin~G~ at the axon proximal segment. The cDNAs of 270-kD ankyrin~G~ and its variants lacking the serine-rich and/or tail domains are transfected into 8-d-old DRG culture using Helios™ Gene Gun system. Expression of transfected proteins is visualized by immunostaining of the GFP tag. The transfected 270-kD ankyrin~G~ (*Ank270-GFP*) is highly restricted to the proximal segment (*A*). High zoom recording reveals plasma membrane stain of the transfected 270-kD ankyrin~G~ at the proximal segment (*B*) and the cell body (*C*). The restricted location of transfected Ank270--GFP (*D*) is displayed against the full length of the transfected axon which is revealed by double labeling of the cotransfected cytoplasmic domain-deleted neurofascin (*E*). The transfected 190-kD ankyrin (Ank270\[ΔSR,T\]--GFP) is also localized at the plasma membrane of the proximal segment (*G*) and the cell body (*H*). However, a significant amount of the transfected Ank270(ΔSR,T)--GFP is distributed beyond the proximal segment into the axon (*F*). Insertion of the tail domain into Ank270(ΔSR,T)-- GFP (Ank270\[ΔSR\]--GFP) improves but does not totally restore restriction of the transfected ankyrin to the proximal part of the axon (*I*). *J* and *K* show membrane localization of Ank270(ΔSR)--GFP at the proximal segment and the cell body respectively. Bar, 25 μm.](JCB9806060.f3){#F3}

![The immunofluorescence intensity profile of transfected ankyrins along the length of axons. The immunofluorescence intensity of the GFP tag of transfected ankyrins is measured using Carl Zeiss LSM measurement program. The distance is calculated from the starting region of the proximal segment. The fluorescence intensity is normalized to the intensity at the plasma membrane of the cell body. (*A*) Measurement of the intensity drop along the length of the axon. (*B*) Two-thirds of the intensity-drop distance (the distance for the intensity of immunofluorescence to drop to one-third of the intensity at the starting region of the proximal segment). Data in *B* represent the mean ± SEM for five transfected neurons.](JCB9806060.f4){#F4}

![The spectrin-binding domain and the tail domain of ankyrin~G~ contain binding sites to the axolemma of axon proximal segments. Different domains of 270-kD ankyrin~G~ tagged with GFP at their COOH termini were individually transfected into DRG neurons. Expression of transfected proteins is examined by immunostaining of the GFP tag. The spectrin-binding domain SB-GFP (*A* and *B*) and the tail domain T-GFP (*K* and *L*) are targeted to the plasma membrane of the proximal segment and the cell body. The membrane-binding domain M-GFP (*E* and *F*), COOH-terminal domain Ct-GFP (*I* and *J*), and the serine-rich domain SR-GFP (*G* and *H*), however, are predominantly localized in the cytoplasm of the axon and the cell body. The spectrin-binding domain of ankyrin~B~ (*SB-GFP \[ankyrin~B~\]*) is not targeted to the axolemma of the proximal segment (*C*), although a small fraction is distributed at the membrane of the cell body (*D*). Bar, 25 μm.](JCB9806060.f5){#F5}

![The immunofluorescence intensity profile of transfected spectrin-binding and tail domains of ankyrin~G~ in axons. (*A*) Immunofluorescence profile. (*B*) the two-thirds intensity-drop distance of transfected spectrin-binding and tail domains. Data represent the mean ± SEM for five transfected neurons.](JCB9806060.f6){#F6}

![Association of 270-kD ankyrin~G~ to the plasma membrane of human kidney 293 cells requires the membrane-binding domain and cotransfected neurofascin. Transfected 270-kD ankyrin~G~ (*Ank270-GFP*) alone visualized by the GFP fluorescence distributes throughout the cytoplasm of 293 cells (*A*). Cotransfection with neurofascin (*HA--NF*) recruits Ank270--GFP to the plasma membrane (*C*). (*B*) Double labeling of cotransfected neurofascin by immunostaining of the HA epitope. The membrane-binding domain of ankyrin (*M-GFP*) is sufficient to be recruited to the plasma membrane (*E*) by cotransfected neurofascin (*D*). Deletion of the first half of the membrane-binding domain (*Ank270(ΔM1,2)--GFP*) abolishes the membrane-recruitment by cotransfected neurofascin (*F* and *G*). Bar, 3 μm.](JCB9806060.f7){#F7}

###### 

Multiple domains of 270-kD ankyrin~G~ contribute to immobilization of ankyrin~G~ at the plasma membrane of human kidney 293 cells. (*A*) FRAP plasma membrane-localized 270-kD ankyrin~G~ and its variants with deleted domains. Ankyrins with the membrane-binding domain are capable of being recruited to the plasma membrane by cotransfected neurofascin HA--NF or the extracellular domain-truncated neurofascin HA--NF(ΔEC) ([@B41]). Dynamics of membrane-associated ankyrins are evaluated by fluorescence recovery measurement after photobleaching the GFP signals. Also included are the FRAP of cytoplasm-located 270-kD ankyrin~G~ and membrane-associated GFP-neurofascin (*HA--NF--GFP*). (*B*) Comparison of recovery rate (the time taken to achieve half of the 50-s recovery) and recovered fraction (the fraction recovered after 50 s) between the cytoplasm-localized ankyrin and the membrane-associated ankyrin. (*C*) Recovery rate and recovered fraction of membrane-associated ankyrins. HA--NF--GFP is measured as a reference for freely diffusing membrane proteins. Data in *B* and *C* represent the mean ± SEM for six experiments.
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